Growth inhibition of luteolin on HepG2 cells is induced via p53 and Fas/Fas-ligand besides the TGF-β pathway

By              

International Journal of Oncology, Vol. 47, Iss. 2, 2015-01 ,pp. : 747-757

Spandidos Publications

Access to resources Recommend Favorite

The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas

By Gutierrez L.S.  

Breast Cancer Research and Treatment, Vol. 54, Iss. 3, 1999-04 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

Cytometric analysis of Fas and Bcl-2 expression in normal prostatic epithelium and prostate cancer

By Diaz J.I.   Pow-Sang J.M.   Mora L.B.   Seigne J.D.   Cantor A.B.   Dalton W.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 5, Iss. 4, 2000-07 ,pp. : 149-154

Elsevier

Access to resources Recommend Favorite

Expression of Bcl-2 Protein in Human Primary Breast Carcinomas and its Correlation with Multifocality, Histopathological Types and Prognosis

By Papadimitriou C.S.   Costopoulos J.S.   Christoforidou B.P.   Kotsianti A.J.   Karkavelas G.S.   Hytiroglou P.M.   Koufogiannis D.J.   Nenopoulou H.E.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1275-1280

Elsevier

Access to resources Recommend Favorite

Analysis of Fas and Fas ligand expression and function in lung cancer cell lines

By Kawasaki M.   Kuwano K.   Nakanishi Y.   Hagimoto N.   Takayama K.   Pei X.-H.   Maeyama T.   Yoshimi M.   Hara N.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 656-663

Elsevier

Access to resources Recommend Favorite